Inhibitory Effect of Apixaban Compared With Rivaroxaban and Dabigatran on Thrombin Generation Assay
Author:
Publisher
Informa UK Limited
Subject
General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.3810/hp.2013.02.1009
Reference29 articles.
1. Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
2. Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor
3. Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
4. Apixaban, an oral, direct factor X a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
5. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03
2. Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro;Journal of Thrombosis and Haemostasis;2023-01
3. Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases;Frontiers in Cardiovascular Medicine;2022-11-10
4. Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements;Frontiers in Cardiovascular Medicine;2021-09-09
5. Corrigendum to “Anticoagulant activity of oral rivaroxaban in healthy dogs” [Vet. J. 223 (2017) 5–11];The Veterinary Journal;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3